Trulieve Becomes First U.S. Cannabis Company to Secure a NYSE Listing

Trulieve Cannabis (CSE: TRUL) is about to cross a threshold the U.S. cannabis industry has spent years waiting for, with the company announcing this morning that it is set to uplist to a major American exchange.

The company said its subordinate voting shares have been cleared to list on the New York Stock Exchange, where they will begin trading under the ticker “TRLV” at the open on June 10. Trulieve bills itself as the first U.S. cannabis operator to reach a senior U.S. listing, a distinction that until recently would have been impossible under federal law.

That changed in April, when Acting Attorney General Todd Blanche reclassified medical marijuana to Schedule III, acting on an executive order President Trump signed in December. The final order rescheduled state-licensed medical marijuana products and opened a registration pathway with the Drug Enforcement Administration for the businesses that handle them.

Cambria Gold Mines — sponsored Sponsored · Cambria Gold Mines

The reclassification also lead to Trulieve reshaping itself. The company completed a corporate restructuring and took on a third party investment that deconsolidated its operations in states serving both medical and adult-use customers. What remains on its consolidated books is strictly state licensed medical marijuana activity, consisting of 206 dispensaries backed by 3.5 million square feet of DEA-registered production capacity.

“As the first U.S. cannabis company to list on a major U.S. exchange, we are excited for the opportunity to expand our shareholder base,” said Founder and Chief Executive Officer Kim Rivers, “Uplisting to the NYSE is a major advancement for Trulieve and the industry.”

“With robust cash generation and meaningful catalysts ahead including expansion in Georgia and Texas, Trulieve is well positioned to deliver on our promise to increase access to medical cannabis for U.S. patients.”

The listing does not require any action from existing holders. The shares are expected to keep trading on the Canadian Securities Exchange under “TRUL” and on the OTCQX under “TCNNF” until markets close on June 9, after which the NYSE listing takes over.

Trulieve last traded at $13.80 on the TSX.


Information for this story was found via the sources and companies mentioned. The author has no securities or affiliations related to the organizations discussed. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Inside a Forgotten High-Grade Gold Mine in the Yukon | Blue Jay Gold [DD-on-the-GO Ep. 10]

WHICH MINING STOCKS CAN STILL RUN? | Mining Stock Mailbag [Nov. 9-13]

Silver’s Bull Market Isn’t Over | Peter Krauth

Recommended

First Phosphate Adds UK Export Finance to Growing Export Credit Lineup With C$220 Million Letter of Interest

Epic Gold Outlines 150,700 Indicated Ounces at 2.26 G/T in Updated Benoist Resource

Related News

Merger Of The Greats: Stifel Provides Green Thumb, Trulieve Merger Rumour Thoughts

In a note sent to investors this morning, Andrew Partheniou of Stifel GMP headlined, “A...

Thursday, August 27, 2020, 01:31:38 PM

Trulieve Sees Canaccord Maintain $35 Price Target Days Before Share Unlock

Trulieve Cannabis (CSE: TRUL) this morning saw Canaccord Genuity reaffirm its speculative buy rating on...

Wednesday, May 13, 2020, 11:20:52 AM

Trulieve Prices Public Offering At C$198.1 Million

Trulieve Cannabis (CSE: TRUL) this evening released the pricing of their previously announced public offering...

Wednesday, April 7, 2021, 08:26:04 PM

Trulieve: A League Of Their Own

Trulieve Cannabis Corp (CSE: TRUL) leads US multi-state operators and the sector as a whole...

Wednesday, August 21, 2019, 02:02:20 PM

Grizzly Reports Accuses Trulieve of Fraud, Insider Dealing

This morning, short selling research firm Grizzly Reports released a report on that of cannabis...

Tuesday, December 17, 2019, 09:58:42 AM